IONIS PHARMACEUTICALS INC — Director's Dealing 2019

Oct 17, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IONIS PHARMACEUTICALS INC (IONS)
CIK: 0000874015
Period of Report: 2019-10-15

Reporting Person: Reikes Peter N (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-15	Common Stock	M	1778	—	Acquired	1778	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-15	Restricted Stock Units	$	M	1778	Disposed		Common Stock (1778)	Direct

Footnotes

F1: Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards.

F2: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.

F3: Restricted Stock Units vest in four equal annual installments. Upon vesting, the Restricted Stock Units will be paid out in whole shares of Ionis common stock or cash as may be determined by Ionis.